Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT03829059 |
Other study ID # |
GCG |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
June 1, 2018 |
Est. completion date |
February 2026 |
Study information
Verified date |
October 2023 |
Source |
Medical University of Graz |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
This retrospective study will evaluate the patient collective of the Division of Oral Surgery
and Orthodontics, Department of Dental Medicine and Oral Health and of the Division of
Cranio-Maxillofacial Surgery at the Medical University Graz concerning the frequency of
epulis/giant cell lesion or underlying differential diagnoses and immunophenotypes as well as
the resulting treatment methods and their success and compare these with international
results
Description:
Different histopathological differential diagnoses can underlay the clinical presentation of
an epulis. Often the immunophenotype of these lesions is of particular importance. This also
holds for the the central giant cell lesion.
This study will evaluate the patient collective of the Division of Oral Surgery and
Orthodontics, Department of Dental Medicine and Oral Health and of the Division of
Cranio-Maxillofacial Surgery at the Medical University Graz concerning the frequency of
epulis/giant cell lesion or underlying differential diagnoses and immunophenotypes as well as
the resulting treatment methods and their success and compare these with international
results.
This is a retrospective study using electronic patient records, written records, operative
reports of the Division of Oral Surgery and Orthodontics, Department of Dental Medicine and
Oral Health and of the Division of Cranio-Maxillofacial Surgery at the Medical University
Graz in the period from 1986 to March 2018. It is intended to gather the data within 12
months and analyze statistically subsequently.